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The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator-1b (PGC-1b) has been
implicated in important metabolic processes. A mouse lacking PGC-1b (PGC1bKO) was generated and phenotyped
using physiological, molecular, and bioinformatic approaches. PGC1bKO mice are generally viable and metabolically
healthy. Using systems biology, we identified a general defect in the expression of genes involved in mitochondrial
function and, specifically, the electron transport chain. This defect correlated with reduced mitochondrial volume
fraction in soleus muscle and heart, but not brown adipose tissue (BAT). Under ambient temperature conditions, PGC-
1b ablation was partially compensated by up-regulation of PGC-1a in BAT and white adipose tissue (WAT) that lead to
increased thermogenesis, reduced body weight, and reduced fat mass. Despite their decreased fat mass, PGC1bKO
mice had hypertrophic adipocytes in WAT. The thermogenic role of PGC-1b was identified in thermoneutral and cold-
adapted conditions by inadequate responses to norepinephrine injection. Furthermore, PGC1bKO hearts showed a
blunted chronotropic response to dobutamine stimulation, and isolated soleus muscle fibres from PGC1bKO mice have
impaired mitochondrial function. Lack of PGC-1b also impaired hepatic lipid metabolism in response to acute high fat
dietary loads, resulting in hepatic steatosis and reduced lipoprotein-associated triglyceride and cholesterol content.
Altogether, our data suggest that PGC-1b plays a general role in controlling basal mitochondrial function and also
participates in tissue-specific adaptive responses during metabolic stress.
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Introduction
Transcriptional coactivators (TCs) have emerged as key
proteins that are capable of regulating entire metabolic
networks [1]. TCs are often selective with respect to the
repertoire of transcription factor partners. The mechanisms
used to modulate transcription may vary according to the
speciﬁc TC, their transcription factor partners, and the
nucleic acid environment in which they operate. TCs provide
an additional layer of control by facilitating temporal and
tissue-speciﬁc regulation of metabolic pathways [1].
Peroxisome proliferator-activated receptor-gamma coacti-
vator-1a (PGC-1a, previously known as PGC-1) [2] is involved
in coordinating diverse organ-speciﬁc transcription pro-
grams. For example, PGC-1a not only activates the thermo-
genic program in brown adipose tissue (BAT) in response to
environmental cold exposure but also modulates the meta-
bolic transition from the fed to the fasted state in the liver [2–
4]. Two other PGC-1a-related genes have subsequently been
found, PGC-1-related coactivator (PRC) [5] and PGC-1b
(PERC/ERRL-1) [6–8]. All three family members share a
similar basic structure; an N-terminal domain containing
nuclear hormone receptor–interacting motifs (the LXXLL
motifs) and a C-terminal region containing RNA-binding
motifs (RMM) and serine-arginine rich (RS) domains. Where-
as PRC is primarily an activator of nuclear respiratory factor-
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1 [5], PGC-1a and PGC-1b have a broader repertoire of
partners [7,9–12].
The gene expression level of PRC is conserved between
tissues [5], but the highest expression of PGC-1a and PGC-1b
is found in oxidative tissues, including BAT, heart, and
skeletal muscle [2,6,7]. However, despite this overlap of
expression pattern, PGC-1a and 1b display different
responses to physiological stimuli. Whereas PGC-1a is tran-
scriptionally up-regulated in BAT and skeletal muscle during
cold exposure, PGC-1b expression remains stable under these
conditions [2,6,7]. Furthermore, up-regulation of PGC-1a is
essential for a normal response to acute cold exposure,
indicating that PGC-1b is not able to compensate for all
aspects of a lack of PGC-1a [13,14]. Similarly PGC-1a is up-
regulated in liver in response to fasting, whereas PGC-1b
expression remained stable [6,7,9], further suggesting that
PGC-1a is more often regulated transcriptionally than PGC-
1b.
Overexpression studies both in vivo and in vitro have
revealed that both PGC-1a and1b are capable of stimulating
mitochondrial biogenesis, increasing mitochondrial oxygen
consumption, and elevating gene expression of fatty acid
oxidation and mitochondrial electron transport chain (ETC)
components [7,9,15]. In addition, bioenergetic studies of
C2C12 myotubes demonstrated that overexpression of PGC-
1a or 1b enhances mitochondrial proton leak [15]. Thus
PGC-1b increases mitochondrial energy production through
a combination of activated fatty acid oxidation gene
expression with increased mitochondrial activity. A role for
PGC-1b enhancing mitochondrial activity is further sup-
ported by the fact that transgenic overexpression of PGC-1b
in mice results in elevated energy expenditure, resistance to
high-fat diet (HFD), and genetically induced obesity [10].
Despite their functional similarities, it has recently been
suggested that PGC-1a and1b may have differing metabolic
roles in liver. PGC-1a stimulates expression of gluconeogenic
genes both in vivo and in vitro [3,9,13,16], and based on data
from mice exposed to a diet enriched in saturated fat for a
short period of time, it appears that PGC-1b but not PGC-1a
interacts with SREBP and LXRa to enhance hepatic lipo-
genesis and lipoprotein secretion [11]. In addition, PGC-1b
interacts with Foxa2 to facilitate hepatic secretion of very low
density lipoprotein (VLDL) [17], suggesting a central role for
PGC-1b in hepatic lipid metabolism. The second organ where
PGC-1a and 1b are also highly expressed is the heart [2,6],
but only the role of PGC-1a in cardiac energy metabolism has
been studied in detail. Overexpression of PGC-1a in cardiac
muscle in vivo leads to uncontrolled mitochondrial prolifer-
ation, leading to cardiomyopathy and congestive heart failure
due to contractile dysfunction [18,19]. Similarly, PGC-1a
knockout mice also develop heart failure with abnormal heart
rate and impaired ventricular function [14,20], again suggest-
ing that despite their similar mode of action, PGC-1b is
unable to compensate fully for a lack of PGC-1a.
To investigate the function of PGC-1b, we have generated
and phenotyped a mouse model lacking PGC-1b (the
PGC1bKO mouse). Using a combination of physiological
experiments guided by a systems biology approach, we
showed that PGC-1b plays a general role in regulating the
mitochondrial activity in tissues with active oxidative
metabolism. In all tissues studied, lack of PGC-1b was
associated with a reduction in the expression of mitochon-
drial genes, including intermediary subunits and enzymes
connected to ETC and oxidative phosphorylation (OxPhos).
Despite these mitochondrial defects, the PGC1bKO mouse
was able to cope when challenged with a range of
physiological stressors including cold acclimatisation and
adrenergically-mediated BAT and cardiac stimulation but
with abnormal compensatory responses. Altogether, these
data suggest that PGC-1b is an important regulator of basal
energy homeostasis and essential for the proper metabolic
tuning in acute stress situations in multiple organs.
Results
Generation of a PGC1bKO Mouse
A conditional PGC1bKO was generated using a triple LoxP
targeting vector (Figure 1A) as detailed in the Material and
Methods. Murine PGC-1b is alternatively spliced at the 59 end
[7] and at exon 4 [8,10]. Exons 4 and 5, which encode two of
the nuclear hormone receptor interacting motifs (LXXLL),
were deleted. Ablation of these exons also introduced a
premature stop codon. PCR and Southern analyses of the
selected clone conﬁrmed the presence of the single LoxP in
intron 5 and that the embyronic stem (ES) cell clone
contained all three LoxP sites as designed (Figure 1B and
1C). Germ line transmission of the modiﬁed PGC-1b allele was
conﬁrmed by PCR analysis of the agouti pups obtained from
chimeras bred to C57BL/6 wild-type (WT) mice. Heterozygous
triple-LoxP–containing mice were then bred with ROSA26-
Cre mice to generate mice heterozygous for the PGC-1b
deletion. Total LoxP site recombination was detected using
PCR from genomic DNA (Figure 1D) and RT-PCR from
isolated RNA. Intercross breeding of heterozygous germ-line
knockout animals produced litters that did not deviate
signiﬁcantly from the expected Mendelian ratio of genotypes,
and the size of litters from PGC1bKO heterozygous crosses
was normal (averaging seven to eight pups per breeding event
per female).
Effect of PGC-1b Ablation on Energy Balance: Reduced
Body Weight and WAT Content Consistent with Increased
Energy Expenditure
No differences in food intake, total energy intake, total
energy output as faeces, and no change in the ratio of energy
in (as food) to energy out (as faeces) (Table S1) were detected
in 12-wk-old male mice selected for equal body weight.
Oxymax analysis revealed increased minimum metabolic rate
at 22 8C in 9-wk-old male PGC1bKO mice (Table 1). No
differences in spontaneous activity (unpublished data) or in
respiratory exchange ratio (RER) were detected, suggesting
that there was no difference in whole-body substrate-type
utilization. Consistent with an elevated minimum metabolic
rate at ambient temperature, PGC1bKO mice weighed less
than their WT littermates (Figure 2A). A similar pattern was
also observed in female PGC1bKO mice.
Body composition analysis using dual energy x-ray absorp-
tiometry (DEXA) conﬁrmed decreased body weight at the
expense of fat mass rather than lean mass in both young (8-
wk) and older (27-wk) male PGC1bKO mice compared to WT
littermates (Figure 2B). This was conﬁrmed in an independ-
ent group of weight-matched 14-wk-old male PGC1bKO mice
that had smaller gonadal adipose tissue depots than WT
littermates. Other organs examined did not show differences
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in their weights relative to body weight (Table S2). Histo-
logical analysis of male gonadal WAT from PGC1bKO mice
showed a reduced fraction of small adipocytes (up to an area
of 2,000 lm2) and an elevated fraction of larger adipocytes in
the PGC1bKO WAT (Figure 2C and 2D). This pattern for
larger white adipocytes was also seen in male subcutaneous
and omental WAT and in female gonadal WAT (Figure S1).
Therefore, when on a chow diet, the PGC1bKO mice had less
total WAT content than WT did, but it was composed of
larger adipocytes. Histological analysis of other metabolically
relevant tissues—including BAT, liver, skeletal muscle, and
pancreas—did not reveal morphological alterations in
PGC1bKO mice under basal conditions (Figure S2).
Gene expression analysis of gonadal WAT from male
Figure 1. Generation of the PGC1bKO Mouse
(A) Design of the targeting construct for the generation of the PGC1bKO mouse using a phosphoglycerate kinase-neomycin phosphotransferase (PGK-
Neo)–based LoxP cassette inserted between exons III and IV and a third LoxP site between exons V and VI. Total collapse of the LoxP sites deletes exons
4 and 5 of the PGC-1b gene.
(B) A Southern blot confirming the generation of the targeted allele in ES cells. WT, wild type ES cells;þ/T, ES cells heterozygous for the targeted allele, T.
(C) Schematic showing the restriction digest strategy for the southern blot confirming the generation of the targeted allele in ES cells. P, PsiI; X, XmaI; S,
SpeI.
(D) Confirmation of the total LoxP collapse and generation of KO mice by PCR from genomic DNA using primers F1, R1, and R2 shown in (A).
DOI: 10.1371/journal.pbio.0040369.g001
Table 1. Assessment of Energy Expenditure on 9-wk-Old Male Chow-Fed PGC1bKO and WT Mice
Measurement 9-wk-old WT 9-wk-old PGC1bKO p Value
Minimum VO2 (ml/min) 0.39 6 0.05 0.52 6 0.03 p ¼ 0.07
Maximum VO2 (ml/min) 1.47 6 0.06 1.40 6 0.05 NS
Minimum VO2 (ml/kg/min) 16.1 6 2.3 22.6 6 1.8 p ¼ 0.05
Maximum VO2 (ml/kg/min) 59.9 6 1.7 60.8 6 3.0 NS
Minimum VO2 (ml/kg[lean]/min) 20.0 6 2.7 27.3 6 2.0 p ¼ 0.05
Maximum VO2 (ml/kg[lean]/min) 74.5 6 2.0 73.5 6 3.2 NS
Minimum VO2 (ml/kg
0.75/min) 6.4 6 0.9 8.8 6 0.6 p ¼ 0.05
Maximum VO2 (ml/kg
0.75/min) 23.7 6 0.7 23.7 6 1.0 NS
RER 0.88 6 0.01 0.90 6 0.01 NS
Oxygen consumption and the respiratory exchange ratio of male WT and PGC1bKO mice was measured at 9 wk old, in mice housed and measured at 22 8C. Minimum values refer to the
average of the three lowest VO2 value recorded during the final 24 h of the experimental procedure, with maximum values referring to those corresponding to the highest three values of
VO2 during this period. VO2 measurements are given related per mouse (ml/min) to total body weight (ml/kg/min), lean body weight (ml/kg [lean]/min), and using the scaling factor of
0.75 (ml/kg0.75/min). The RER was calculated as the average RER measurement during the final 24 h of the procedure. n¼ 5–7 mice per group.
NS, not significant.
DOI: 10.1371/journal.pbio.0040369.t001
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PGC1bKO mice and WT littermates showed no signiﬁcant
change in markers of adipogenesis including C/EBPa,
PPARc2, aP2, and GLUT4 (Figure 2E). There was a signiﬁcant
up-regulation of PGC-1a expression in WAT in the absence
of PGC-1b (Figure 2E). Previously, increased PGC-1a ex-
pression in WAT has been associated with the development of
a BAT-like phenotype [21]. However, increased expression of
PGC-1a was not sufﬁcient to increase UCP1 and D2-
deiodinase expression in PGC1bKO WAT (unpublished data).
Combined with the WAT morphology data, elevation of PGC-
1a in the PGC1bKO WAT is not enough to result in clear
BAT-like adipose tissue. However, ablation of PGC-1b
resulted in reduced expression in the ETC genes CytC and
Cytochrome Oxidase subunit (Cox) 5b and also in leptin (p¼ 0.06).
Figure 2. The PGC1bKO Mouse Has Altered Metabolism under Standard Environmental Conditions
(A) Growth curves of male (left panel) and female (right panel) mice on normal diet. WT (solid circles) and PGC1bKO (open circles) mice, n¼ 18–21 mice
per group.
(B) Assessment of fat content by DEXA in 8- and 32-wk-old male WT (solid bars) and PGC1bKO mice (open bars), n¼ 8–12 mice per group.
(C) Representative histological sections of tissues from WAT (n ¼ 6).
(D) Size distribution of adipocytes from WT and PGC1bKO mice. Two fields from each section from epididymal adipose tissue depot (n¼ 4 mice per
genotype) were analysed to obtain the mean cell area per animal.
(E) Epididymal WAT gene expression from 12-wk-old PGC1bKO (white bars) and WT littermates (black bars). Individual measurements are standardized
using 18S, and then the average of the WT group was set to 1. n ¼ 5–8 mice per group.
DOI: 10.1371/journal.pbio.0040369.g002
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Ablation of PGC-1b did not result in differences in basal
levels of plasma glucose or insulin. Similarly, glucose
tolerance tests and insulin tolerance tests (GTTs and ITTs,
respectively) performed on 16-wk male and female mice
either on chow or after a 13-wk HFD did not reveal
differences among genotypes (Figure S3). Therefore, the
PGC1bKO mouse is leaner, has increased energy expenditure,
and remains insulin sensitive.
Reduced Expression of ETC Components Despite
Increased PGC-1a mRNA Expression in the BAT of
PGC1bKO mice
Examination of BAT in chow-fed 12-wk-old PGC1bKO
male mice and WT littermates showed major changes in the
expression of genes involved in intermediary metabolism
(Figure 3). At ambient temperature, we identiﬁed a 4-fold
compensatory increase in the expression of PGC-1a when
PGC-1b was ablated. We also observed a 5.9-fold elevation in
the thyroid-dependent pro-thermogenic enzyme D2-deiodi-
nase. These changes were associated with up-regulation in
PGC1bKO mice of genes involved in glucose and fatty acid
metabolism (including GLUT4, PPARa, ADRP, LPL, and HSL)
as well as elevations in PPARc1 and 2 and all three UCP
isoforms. These changes suggested that increased PGC-1a
expression was overcompensating for a lack of PGC-1b.
Despite this up-regulation of PGC-1a, ablation of PGC-1b still
resulted in a speciﬁc decreased expression of genes involved
in mitochondrial ETC such as Cox5b and CytC. In addition, a
further range of mitochondrially encoded (Figure 4A) and
nuclear-encoded (Figure 4B) ETC mRNAs were also reduced
in PGC1bKO mouse BAT. The mitochondrially encoded Cox2
was the only ETC subunit measured in PGC1bKO BAT with
increased expression. Western blotting analysis of ETC
components in BAT lysates from 15-wk-old female mice
revealed decreases in subunits from complexes I to IV in
PGC1bKO mice (Figure 4C). Similarly, assessment of succi-
nate dehydrogenase subunit B (SDHB, complex II) and Cox4
protein levels in isolated mitochondrial preparations were
both reduced in PGC1bKO mice (Figure 4D). ATP synthase
subunit b was unchanged. Taken together, these results
demonstrate defective ETC expression and protein compo-
sition in the BAT of PGC1bKO mice, which cannot be fully
compensated for by up-regulation of PGC-1a. Despite these
defective changes, mitochondrial volume fraction was only
marginally affected in BAT of PGC1bKO mice (Figure 4E, WT
versus PGC1bKO: 5.0 6 0.3% versus 4.4 6 0.2%, n ¼ 4 mice
per group, p ¼ not signiﬁcant [NS]) and there was no
difference in BAT lipid content as determined by light
microscopy (WT versus PGC1bKO: 13.7 6 0.8 versus 13.1 6
0.9, n¼ 4 mice per group, p¼NS). This suggests that the up-
regulation of PGC-1a in BAT can compensate some, but not
all, aspects of the mitochondrial system in this tissue.
PGC1bKO Mice Are Cold-Tolerant but Display Abnormal
Responses to Norepinephrine-Induced Energy
Expenditure
A stepwise acclimatisation to cold exposure (4 8C) and
towards thermoneutrality (30 8C) was performed on male
mice that were 16 wk old at the end of the 3-wk cold-
acclimatisation process. The rationale for these experiments
was to identify the contribution of PGC-1b to energy
expenditure in these two directly opposing thermogenic
scenarios. PGC1bKO mice survived at 4 8C after this
acclimatisation process. BAT pad weight was similarly
increased by cold-acclimatisation in both WT (BAT weight
in mg for 30 8C versus 4 8C: WT 117.8 6 7.1 versus 145.5 6
9.4, p, 0.05, n¼5 mice per group) and PGC1bKOmice (107.9
6 9.1 versus 160.0 6 10.3, p , 0.01, n ¼ 4 mice per group),
without differences in BAT weight between the genotypes in
either condition. Cold-acclimatised PGC1bKO mice had
decreased basal metabolic rate compared to WT (Figure 5A)
and had a higher RER than WT mice, suggesting that PGC1b-
deﬁcient adaptation to cold exposure may involve prefer-
ential use of carbohydrates (Figure 5B). Thermoneutrality
studies showed that contrary to the increased resting
metabolic rate observed at ambient temperature, when
PGC1bKO mice are housed and measured at thermoneu-
trality, they have reduced basal metabolic rate compared to
WT (Figure 5A). Of note, PGC-1a up-regulation observed in
PGC1bKO mice at ambient temperature was prevented at
thermoneutrality (see below).
To test the maximal BAT-based nonshivering thermo-
genesis capacity, we used a norepinephrine (NE) challenge
(Figure 5C). Whereas NE provoked the expected large (almost
4-fold) increase in O2 consumption in cold-adapted WT mice,
the same stimulus in cold-adapted PGC1bKO mice only
reached 60% of the WT response. (Figure 5C). NE admin-
istration to mice kept at thermoneutrality revealed that
whereas WT mice exhibited a physiological small increase in
O2 consumption after being given NE, O2 consumption in the
PGC1bKO mice housed at thermoneutrality was essentially
unaffected by NE. This demonstrates that the ability of the
BAT to mediate thermoregulatory thermogenesis after a
period of cold acclimatisation or during thermoneutrality is
blunted by the absence of PGC-1b.
Gene expression of BAT from cold-acclimatised and
thermoneutrally maintained mice was analysed. Comparison
of gene expression patterns between WT and PGC1bKO mice
housed at 30 8C (Figure 5D) revealed the same differences
between the genotypes as previously seen in mice housed at
ambient temperatures (Figure 3). In addition, many of the
genes examined concerning fuel handling (e.g., SREBP1c,
Figure 3. PGC-1b Ablation Results in Major Changes in BAT Metabolic
Gene Expression
Expression levels of mRNA were assessed on interscapular BAT from 12-
wk-old male WT (black bars) and PGC1bKO (white bars) mice. Individual
measurements are standardized using 18S, and the average of the WT
group set to 1. n¼ 5–7 mice per group.
DOI: 10.1371/journal.pbio.0040369.g003
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GLUT4, LPL, PPARc) were similar in cold-acclimatised WT
and PGC1bKO mice (Figure 5D, left panel). However, cold-
acclimatised PGC1bKO BAT still had decreased expression of
the ETC genes Cox4, Cox5b, and CytC (Figure 5D, right panel).
Similarly, there was signiﬁcantly lower expression of UCP1
and MCAD in cold-acclimatised PGC1bKO BAT than in WT.
With cold exposure, PGC-1amRNA was increased to a similar
extent in both WT and PGC1bKO mice, and PGC-1b
expression was increased in WT mice. Also, as indicated
above, there was no difference in PGC-1a expression between
the genotypes at thermoneutrality. As expected, cold accli-
matisation increased levels of UCP1 protein in WT (total
interscapular BAT UCP1 protein 30 8C versus 4 8C, stand-
ardised to WT 4 8C: 12.9 6 2.8 versus 100.0 6 7.4; n¼ 5 mice
per group) and also in PGC1bKO mice (14.9 6 2.9 versus
140.9 6 19.9; n¼ 4 mice per group). Total BAT UCP1 protein
was near-signiﬁcantly elevated (p¼ 0.07) in cold-acclimatised
PGC1bKO mice compared to cold-acclimatised WT mice.
Figure 4. PGC-1b Ablation Reduces ETC Gene and Protein Expression but Mitochondrial Volume Fraction is Unaffected
(A and B) Expression levels of (A) nuclear-encoded and (B) mitochondrially encoded genes were assessed on interscapular BAT from 12-wk-old male WT
(black bars) and PGC1bKO (white bars) mice. Individual measurements are standardized using 18S, and the average of the WT group set to 1. n¼ 5–7
mice per group.
(C and D) BAT protein levels of ETC and OxPhos components from 15-wk-old female mice were assessed by western blotting of samples from (C) tissues
and (D) mitochondrial fractions. WT, black bars and PGC1bKO, white bars. Complex I, a-subcomplex 9 (a-s9); complex II, succinate dehydrogenase
subunit B (SDHB); complex III, Fe-S core protein (Fe-S); complex IV, Cox4; complex V, ATP synthase subunit b (ATPb). n¼5–6 mice for each protein, with
the average value of the WT group set to 1. Representative blots showing two samples from each genotype.
(E) Representative electron micrographs from BAT of WT (left panel) and PGC1bKO (right panel) mice.
DOI: 10.1371/journal.pbio.0040369.g004
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Thus, the inhibition of cold-acclimatisated BAT activity in
PGC1bKO mice occurs as a result of reduced ETC expression,
despite otherwise normal BAT recruitment and UCP1
protein expression.
Gene Expression Pathway Analysis in PGC1bKO Tissues
Shows Global Impairment in Mitochondrial Function and
Substrate Use
Binomial pathway enrichment analysis using pathways
from the Kyoto Encyclopedia Genes and Genomes (KEGG)
was performed on gene expression from spotted arrays
generated from BAT of PGC1bKO and WT mice to identify
alterations in whole genetic pathways (Table 2). Down-
regulated KEGG pathways include OxPhos, ubiquinone
biosynthesis, and ATP synthesis. In addition, we saw decreases
in glycolysis/gluconeogenesis, the citric acid cycle, and many
of the amino acid metabolism pathways that feed substrates
into these systems. Only purine metabolism and glycerolipid
metabolism pathways were signiﬁcantly up-regulated in BAT.
A full list of altered KEGG pathways can be found in Dataset
S1. Similar gene expression pathway analysis was also
performed in liver and heart tissues. We identiﬁed only two
Figure 5. Thermoneutral and Cold-Adapted PGC1bKO Mice Display Reduced Resting and NE-Stimulated Energy Expenditure
Male WT and PGC1bKO mice were acclimatised to 30 8C or 4 8C as stated in the Materials and Methods.
(A) Oxygen consumption per mouse (ml/min). Similar results were obtained when the data were standardised using the body weight (kg)0.75 scaling;
WT, black bars; PGC1bKO, white bars.
(B) RER. Solid circles, WT at 4 8C; open circles; PGC1bKO at 4 8C; solid squares, WT at 30 8C; open squares, PGC1bKO at 30 8C.
(C) Oxygen consumption per mouse (ml/min) measured post-administration of 1 mg/kg norepinephrine.
(D) BAT mRNA expression in thermoneutral and cold-adapted mice. WT thermoneutral, black bars; PGC1bKO thermoneutral, white bars; WT cold-
adapted, dark gray bars; PGC1bKO cold-adapted, light gray bars. Individual measurements are standardized using 36B4 and the average of the WT,
thermoneutral group was set to 1. n ¼ 4–5 mice per genotype per condition for each experiment. * indicate a significant difference between cold-
adapted WT and PGC1bKO mice. ## indicates a significant difference between thermoneutral WT and PGC1bKO mice.
DOI: 10.1371/journal.pbio.0040369.g005
PLoS Biology | www.plosbiology.org November 2006 | Volume 4 | Issue 11 | e3692048
Phenotype of the PGC-1b Knockout Mouse
KEGG pathways, OxPhos, and ATP synthesis that were
decreased in all three tissues—BAT, heart, and liver (Table
S3). This suggests a global role for PGC-1b in the main-
tenance of normal gene expression encoding for mitochon-
drial proteins.
Tissue Mitochondrial Activity, but Not Isolated
Mitochondrial Function, Is Impaired in PGC1bKO Soleus
Muscle
We assessed whether reduced expression of ETC genes
were associated with functional defects in permeabilised
soleus muscle ﬁbres (Figure 6). Both state 3 and state 4
mitochondrial respiration were reduced in PGC1bKO ﬁbres,
suggesting reduced electron chain capacity and OxPhos
activity (Figure 6A). There was no change in the respiratory
control ratio (RCR; state 3/state 4), suggesting that the
differences between WT and PGC1bKO mice were not
related to intrinsic differences in mitochondria function
but to reduced numbers of mitochondria per ﬁbre. In
agreement with this, ATP synthesis was decreased in
PGC1bKO ﬁbres (Figure 6B), and a trend for decreased
ATP/O ratio in PGC1bKO muscle ﬁbres was also observed
(Figure 6C). This suggested that PGC1bKO soleus ﬁbres not
only produce less ATP than WT ﬁbres did, but they were also
less efﬁcient at converting reduced substrate into ATP. Gene
expression analysis of 12-wk-old male soleus muscles demon-
strated that PGC1bKO mice have reduced ETC expression
(Cox4 and Cox5b), which corresponds to reduced soleus
mitochondrial capacity (Figure S4). These results were
supported by a decreased mitochondrial volume fraction in
the soleus of PGC1bKO mice performed by stereological
analysis (WT versus PGC1bKO: 20.4 6 0.7% versus 16.8 6
0.8%, p ¼ 0.012) (Figure 6D).
To assess whether this oxidative defect could be attributed
to the functionality of individual mitochondria, we measured
oxidative activity of isolated soleus mitochondria. In all states
examined, there was no signiﬁcant difference between WT
and PGC1bKO-derived soleus mitochondria (Figure S5). In
addition, no differences amongst genotypes were observed
when RCR (Figure S5B) or proton leak were measured (Figure
S5C).
PGC-1b Ablation Reduces Mitochondrial Content of the
Heart and Blunts the Effect of Adrenergic Stimulation on
Heart Rate
We hypothesized that defective PGC-1b may result in
electromechanical myocardial dysfunction in the hearts of
PGC1bKO mouse. Heart weights from PGC1bKO mice were
similar to WT in chow-fed 14-wk-old male mice (Table S2). In
addition, under basal conditions, PGC1bKO hearts showed
no histological abnormalities compatible with ﬁbrosis or
Table 2. Major KEGG Pathways Are Changed in PGC1bKO Mouse
BAT
Pathway Type Pathway Name p Value
DOWN Oxidative phosphorylation 0.000
Citrate cycle (TCA cycle) 0.000
ATP synthesis 0.001
Pyruvate metabolism 0.015
Galactose metabolism 0.002
Cysteine metabolism 0.001
Reductive carboxylate cycle (CO2 fixation) 0.000
Tyrosine metabolism 0.002
Ubiquinone biosynthesis 0.001
Glycolysis gluconeogenesis 0.004
Phenylalanine metabolism 0.001
Arginine and proline metabolism 0.004
Starch and sucrose metabolism 0.001
Phenylalanine tyrosine and tryptophan biosynthesis 0.003
UP Glycerolipid metabolism 0.042
Purine metabolism 0.046
RNA was isolated from 14-wk-old normal diet-fed male PGC1bKO and WT mice and then
analysed using spotted arrays as described in the Materials and Methods. Data are
displayed as pathway name followed by p value for the binomial test. A pathway p value
of ,0.05 was considered significant.
DOI: 10.1371/journal.pbio.0040369.t002
Figure 6. Isolated Soleus Fibres from PGC1bKO Mice Have Reduced
Mitochondrial Activity
Soleus fibres were isolated from WT (black bars) and PGC1bKO mice
(white bars) and permeabilised to allow measurement of tissue-
associated mitochondrial function.
(A) Mitochondrial respiratory parameters for state 2 (V0), state 3 (VADP),
state 4 (Voligomycin), and respiratory control ratio (RC).
(B) ATP synthesis rates in permeabilised soleus fibres.
(C) ATP/O ratio in permeabilised soleus fibres. Data are standardised to
mg of muscle dry weight (mgdw). n¼ 9 WT mice, 11 PGC1bKO mice.
(D) A representative electron micrograph of soleus muscle from WT (left
panel) and PGC1bKO (right panel) mice.
DOI: 10.1371/journal.pbio.0040369.g006
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inﬂammatory inﬁltrates (unpublished data). The expression
of molecular markers of cardiac hypertrophy, such as a-actin,
natriuretic peptide precursor type B, or troponin I, were all normal
in 24-wk-old male PGC1bKO hearts (Figure 7A). The only
transcriptional change that can be associated with myocardial
dysfunction was the up-regulation of skeletal muscle actin in
PGC1bKO compared with WT mice. PGC-1a mRNA expres-
sion was also unchanged in PGC1bKO hearts. PGC1bKO
hearts had a decreased mitochondrial volume fraction as
indicated by stereological analysis (42.8 6 2.8 % versus 35.3
6 0.3 %, p ¼ 0.05: Figure 7B). Despite this result, PGC1bKO
and WT heart mitochondria were similarly packed between
myoﬁbres, and there were no changes in cristae surface
density, Sv (per unit volume of mitochondria). This suggests
that the internal structure of the mitochondria was normal in
the PGC1bKO hearts. In agreement with the gene expression
pathway analysis, the expression of Cox4 (p ¼ 0.07) and Cox5b
was down-regulated in heart of 14-wk-old PGC1bKO com-
pared with WT mice, whereas Cox2 expression was unchanged
(Figure 7C).
Male, 26-wk-old PGC1bKO and WT littermates were
challenged with acute infusion of the b1,a1-adrenergic
selective agonist dobutamine. Haemodynamic recordings
showed that baseline heart rate and left ventricular contrac-
tility (þdP/dt or –dP/dt) were similar between genotypes. As
expected during infusion of 10 ng dobutamine per min per g
body weight (ng/min/g BW), WT mice increased their heart
rate, an effect that was blunted in PGC1bKO mice (Figure
8A). This inability to increase heart rate was even more
evident using a 40 ng/min/g BW dobutamine infusion (p, 0.05
for 8, 10, and 12 min post-injections). Ventricular perform-
ance during the dobutamine challenge was the same in WT
and PGC1bKO mice (Figure 8B and 8C).
PGC-1b Modulates the Response of the Liver to an Acute
HFD Challenge
Gene expression analysis of fed-state 12-wk-old male mouse
livers showed ablation of PGC-1b but did not result in major
changes in mRNA expression levels (Figure S6). Only Cox4 was
decreased in the PGC1bKO livers, a result that was in
agreement with gene expression pathway analysis (Table
S3). When 8-wk-old female PGC1bKO mice were challenged
with a 24-h period of Surwit HFD, liver mass increased as a
proportion of body weight (Figure 9A). This effect was not
observed in WT mice fed the same diet. Histological analysis
revealed that PGC1bKO mice fed the Surwit diet developed
severe hepatic steatosis compared to WT mice (Figure 9B).
Figure 7. Alterations in Gene Expression and Mitochondrial Dimensions in Hearts of PGC1bKO Mice
(A) Expression levels of mRNA were assessed on hearts from 24-wk-old male WT (black bars) and PGC1bKO (white bars) mice. Individual measurements
are standardized using 18S, and the average of the WT group set to 1. n¼ 5–7 mice per group.
(B) A representative electron micrograph of mitochondria from WT (left panel) and PGC1bKO (right panel) hearts. The bar indicates a measurement of
200 nm.
(C) mRNA expression of key genes for mitochondrial function in 24-wk-old WT and PGC1bKO mouse hearts.
(D) mRNA expression of key genes for metabolic function in 24-wk-old male WT and PGC1bKO mouse hearts.
DOI: 10.1371/journal.pbio.0040369.g007
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Increased fat deposition in PGC1bKO livers was associated
with normal plasma non-esteriﬁed fatty acids (NEFA) levels
(Table 3). As expected, plasma triglyceride levels increased in
WT mice in response to 24-h HFD, however plasma
triglyceride levels were signiﬁcantly lower in PGC1bKO than
WT mice when fed the Surwit diet. When compared to WT
mice, the PGC1bKO mice had lower basal levels of high-
density lipoprotein (HDL) and LDL-associated cholesterol
and elevated VLDL-associated cholesterol. Administration of
a fat-enriched diet increased the amount of cholesterol
associated with VLDL, HDL, and LDL particles in WT mice
(Table 3). However, PGC1bKO mice had inappropriately low
levels of VLDL and blunted increases on total cholesterol and
HDL- and LDL-associated cholesterol in plasma. Thus,
defective PGC-1b results in lipid accumulation in liver and
decreased circulating triglyceride-rich VLDL lipoproteins
following a high-dietary lipid load.
Of interest and contrary to previous reports, we were
unable to detect increases in PGC-1a and PGC-1b mRNAs in
response to acute HFD in WT liver (Figure S7). We observed
that SCD-1 and HMG-CoA reductase were signiﬁcantly elevated
in WT livers in response to Surwit diet compared to chow WT
controls and that similar changes were not observed in
PGC1bKO mouse livers after the Surwit diet (Figure S7).
Discussion
Accumulating evidence indicated that PGC-1b may play a
role in energy homeostasis through its effects on substrate
metabolism and mitochondrial activity [4,6,7,13–15,19].
However, the function and relevance of PGC-1b in the
control of whole-organism energy metabolism is not well
deﬁned. To address this question, we generated and
phenotyped a PGC1bKO mouse model. The PGC1bKO
mouse is viable and apparently healthy. However, using a
phenotyping strategy that combines physiological stress
challenges guided by information obtained from a systems
biology approach, we found that PGC1bKO mice have a
general defect in mitochondrial function, a defect that is
partly compensated for by mechanisms that are usually
involved in adaptation to increased energy demands, such as
up-regulation of PGC-1a.
The effect of PGC-1b controlling mitochondrial activity
was investigated at the mRNA level using spotted array
technology and bioinformatics pathway analysis. This ap-
proach showed that deletion of PGC-1b results in a signiﬁcant
mitochondrial phenotype. Multi-tissue comparisons demon-
strated that PGC-1b controls the level of expression of ETC
and OxPhos genes across all the organs studied and that this
defect can only be partially compensated for in BAT and
WAT by up-regulation of PGC-1a. However, the decrease in
mRNA expression of ETC components is not necessarily seen
at the protein level. These data suggest that although PGC-1b
may be a controller of mitochondrial gene expression, in the
absence of PGC-1b, additional factors such as protein
degradation may be counter-regulated in speciﬁc tissues in
an attempt to normalise levels of mitochondrial activity.
Our initial hypothesis was that dysregulation of ETC gene
Figure 8. PGC1bKO Hearts Display a Blunted Heart Rate Response to
Dobutamine Stimulation In Vivo
PGC1bKO and WT littermates (male, 26-wk-old) were treated as stated in
Material and Methods and infused with 10 or 40 ng/min/g BW
dobutamine to measure in vivo hemodynamic responses WT, solid line;
KO, dashed line.
(A) Percentage change in heart rate from basal during dobutamine
infusion.
(B and C) Measurement of ventricular performance, dP/dt, during
infusion. The arrow marks the increase in dobutamine concentration in
the infusion from 10 to 40 ng/min/g BW. n¼ 5 mice per genotype.
DOI: 10.1371/journal.pbio.0040369.g008
Figure 9. PGC1bKO Mice Demonstrate Increased Liver Mass and
Development of Fatty Liver after 24 h HFD
Female 8-wk-old mice were given normal chow or Surwit HFD (Sur) for
24 h. Tissues were then collected for analysis.
(A) Liver weight, as standardized by body weight (LW/BW) for WT (black
bars) and PGC1bKO (white bars) after 24 h diets.
(B) Representative histological sections from mice given normal or Surwit
diet for 24 h. n¼ 6–7 mice per group.
DOI: 10.1371/journal.pbio.0040369.g009
PLoS Biology | www.plosbiology.org November 2006 | Volume 4 | Issue 11 | e3692051
Phenotype of the PGC-1b Knockout Mouse
expression would increase the likelihood that the PGC1bKO
mouse would become obese. However, despite its mitochon-
drial phenotype, the PGC1bKO mouse showed elevated
resting metabolic rate and lower body weight compared to
wild type littermates under ambient room temperature
conditions. This phenotype is possibly due to the compensa-
tory increase in expression of PGC-1a and its target genes in
BAT. The increase in BAT PGC-1a expression may cause the
higher degree of energy expenditure and relatively conserved
mitochondria volume fraction despite reductions in ETC
gene and protein expression. PGC-1a was also up-regulated
in PGC-1b–deﬁcient WAT, but its induction was not robust
enough to produce a BAT-like histology or induction of
typical BAT genes. Instead, within the reduced WAT content
of the PGC1bKO mice, there was a greater proportion of
larger, hypertrophic adipocytes. This result suggests that
PGC-1b may play an as yet unknown role in white adipocyte
biology, and the nature of this role requires further
investigation.
Of interest, despite marked elevation of PGC-1a levels in
PGC1bKO BAT, we did not observe a full restoration of the
expression of mitochondrial genes back to WT levels.
However, unlike the heart or skeletal muscle, organs where
PGC-1a was not up-regulated, the mitochondrial fraction of
BAT tissue was preserved in PGC1bKO mice. Thus, there may
be partial functional overlap between PGC-1a and PGC-1b,
concerning mitochondrial structure and function, which
allows the development of an appropriate mitochondrial
BAT content but fails to correct deﬁciencies in ETC
composition. BAT was the only tissue out of three metabol-
ically relevant tissues examined using electron microscopy
that displayed relatively normal mitochondrial fraction,
suggesting that further tissue function–speciﬁc mechanisms
may be able to correct for PGC-1b ablation. However, the
BAT gene expression pattern in PGC1bKO mice also showed
altered expression of genes involved in intermediary metab-
olism, a pattern of gene expression that may also be primarily
the result of PGC-1a up-regulation. Our conclusion from
these gene expression analyses is that whereas PGC-1bmay be
required to set the basal level of mitochondrial ETC gene
expression, it is not essential for normal expression of
metabolic pathways such as glycolysis, the citric acid cycle,
and fatty acid oxidation.
We hypothesized that the elevated resting metabolic rate
seen in ambient-temperature housed PGC1bKO mice may be
reversed under conditions of thermoneutrality, particularly if
it was caused by compensatory up-regulation of PGC-1a.
Under thermoneutral conditions, levels of PGC-1a gene
expression are suppressed in BAT in response to the lower
thermogenic and therefore oxidative demands of life at 30 8C.
At thermoneutral conditions, PGC-1a mRNA expression was
equivalent in WT and PGC1bKO BAT. Interestingly, under
thermoneutral conditions, the PGC1bKO mouse exhibited
reduced basal metabolic rate compared to the WT mouse.
The energy expenditure measurements with mice acclima-
tised to 4 8C and 30 8C were performed at 33 8C. This
measurement at thermoneutrality gives an indication of the
basal metabolic rate. Under these experimental conditions,
we can conclude that the PGC1bKO mouse has a reduced
basal metabolic rate. The data from mice housed in ambient
(22 8C) conditions were also generated at ambient conditions
(Table 1). Therefore, this measurement represents energy
expenditure in ‘‘normal’’ environmental conditions, when the
body weights of the PGC1bKO mice are lower than WT.
Under these experimental conditions, this measurement is
composed of both basal metabolic rate and any additional
metabolic effort required to maintain body temperature in
this suboptimal thermal environment. Given that basal
metabolic rate is reduced in 30 8C– and 4 8C–acclimatised
PGC1bKO mice, it could be assumed that at ambient
temperatures, basal metabolic rate is also reduced, but that
the metabolic adaptation required for body temperature
defense is actually greater in the PGC1bKO mouse. This
suggests that PGC-1b may contribute to BAT thermogenesis
in states of low metabolic demand (as is the case for BAT at 30
8C), whereas induction of PGC-1a regulates BAT thermo-
genesis as environmental temperatures fall.
It has been suggested that PGC-1b plays a role in BAT
accumulation and function during cold exposure [6].
PGC1bKO mice tolerated cold acclimatisation, despite the
fact that under these conditions, PGC1bKO mice had
decreased ETC gene expression and had decreased maximal
thermogenic capacity in BAT, as shown by the lower oxygen
consumption rate in response to adrenergic stimulation.
Both WT and PGC1bKO mice up-regulated PGC-1a to a
similar extent under conditions of cold exposure, suggesting
that there is a maximal capacity of PGC-1a up-regulation in
BAT. Alternatively, survival in cold may also be facilitated by
Table 3. Serum Lipid Biochemistry from 24-h Surwit Diet–Fed WT and PGC1bKO Mice
Lipid WT - Chow WT - Surwit PGC1bKO - Chow PGC1bKO - Surwit
Triglycerides (mM) 0.39 6 0.03 a 0.66 6 0.12 a,b 0.21 6 0.04 0.35 6 0.03 b
NEFA (mM) 0.64 6 0.05 0.82 6 0.12 0.60 6 0.05 0.71 6 0.07
Cholesterol (mM) 3.34 6 0.20 a,b 5.37 6 0.24 a,c 2.20 6 0.23 b,d 3.45 6 0.30 c,d
VLDL (mM) 0.026 0.049 0.037 0.025
HDL (mM) 0.29 0.46 0.23 0.35
LDL (mM) 3.06 4.86 1.93 3.07
Female WT and PGC1bKO mice were placed on Surwit diet for 24 h or maintained on normal diet. At the end of the time period, the mice were sacrificed and blood serum analysed. n¼5–
7 mice per condition. For cholesterol-associated lipoproteins, serum samples for each group were pooled and analysed.
aSignificant comparisons between groups.
bSignificant comparisons between groups.
cSignificant comparisons between groups.
dSignificant comparisons between groups.
DOI: 10.1371/journal.pbio.0040369.t003
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the ability of the mice to maintain some fraction of increased
metabolic activity through continued shivering [22–24].
Therefore, although the total metabolic capacity provided
by PGC-1a in cold-exposed PGC1bKO mice was sufﬁcient for
their survival, our results indicate that PGC-1b regulates a
large fraction of the thermogenic capacity of the BAT tissue.
Studies focused in other metabolically relevant organs
where PGC-1b is well expressed also indicated that ablation
of PGC-1b resulted in impaired metabolic capacity. For
example, mitochondrial volume fraction in soleus of
PGC1bKO mice was decreased, and permeabilised soleus
muscle ﬁbres from PGC1bKO mice had reduced oxygen
consumption and ATP synthesis compared to WT-derived
ﬁbres. Similar experiments using isolated soleus mitochon-
dria from PGC1bKO mice failed to show any abnormalities in
metabolic performance, indicating that metabolic defects in
PGC1bKO soleus tissue relate to lower mitochondrial density
relative to WT, although individual mitochondria retain
similar metabolic properties.
The heart is the third oxidative tissue that is a major site of
PGC-1b expression. Absence of PGC-1b in heart also led to a
reduction of mitochondrial fraction, consistent with reduced
cardiac expression of ETC genes. However, despite these
potential bioenergetic defects, PGC1bKO mice have normal
basal heart rates and ventricular contractility. Left ventric-
ular function was also maintained after dobutamine treat-
ment, suggesting that despite their mitochondrial defect, the
PGC-1b–deﬁcient hearts are able to adapt normally to
imposed hemodynamic loads. The only difference in adre-
nergic stress that we observed between the PGC1bKO mice
and WT was a blunting of the expected increase in heart rate
in the PGC1bKO mice. A similar defect in heart rate
regulation was also found in the PGC-1a knockout mice
[14], suggesting that both PGC-1a and PGC-1b may have a
direct effect in controlling the activity of heart pacemakers.
Overall, our results indicate that ablation of PGC-1b impairs
heart mitochondrial function but that this defect is not severe
enough to induce heart failure. However, a more chronic
intervention study would be required to establish the relative
importance of these PGC isoforms in cardiac energy supply
and control.
To this point, we have discussed exclusively a role for PGC-
1b in oxidative metabolism. Nonetheless, PGC-1b may also
play an important role in regulating hepatic lipid production
[11,17]. Contrary to previous reports, we did not observe
either PGC-1b induction after 24-h HFD in the liver of our
control mice or differences in FAS and SREBP1c gene
expression between controls and PGC1bKO mice. However,
we did observe a reduction in circulating total cholesterol
and alterations in the lipoprotein-associated cholesterol
pattern in chow-fed conditions. Feeding for 24 h with a
saturated fat–enriched HFD was associated with severe
hepatic lipid accumulation and decreased total triglycerides,
cholesterol, and VLDL and LDL-cholesterol plasma levels in
PGC1bKO mice compared to WT. These results agree with a
recent report suggesting that PGC-1b is a likely mediator of
VLDL secretion by acting via interactions with Foxa2 to alter
microsomal transfer protein expression [17]. However, it is
also possible that PGC-1b is necessary for additional aspects
of hepatic lipid handling, including modiﬁcation of lipid
storage pathways and for controlling the balance between
fatty acid synthesis and oxidation. Indeed, our pathway
analysis suggests that the ETC in liver is expressed at a lower
level and this may contribute to the steatosis after acute HFD
treatment.
Our results indicate that PGC-1b has a well-deﬁned role in
controlling mitochondrial gene expression and function in
many different organs. Despite this, PGC-1b can be ablated
without overt metabolic failure, at least in unstressed
conditions. This may be due in part to robust compensatory
mechanisms, as demonstrated by the up-regulation of PGC-
1a expression in WAT and BAT. Interestingly, other organs
such as liver, muscle, or heart did not show up-regulation of
PGC-1a under the conditions investigated. Following from
these differences in PGC-1a expression, it is likely that the
lean phenotype of this mouse model at ambient temperature
should be considered the result of overcompensation
mediated by up-regulation of PGC-1a, at least in BAT and
WAT. Conversely, defects observed in skeletal muscle, heart,
and liver are more likely to be the result of the absence of
PGC-1b given the lack of PGC-1a induction in those tissues.
When considering the roles played by PGC-1a and PGC-1b,
our results show that there are speciﬁc effects of PGC-1b that
cannot be compensated for by PGC-1a. Taken altogether, our
results indicate that PGC-1b seems to cover basal bioen-
ergetic needs whereas PGC-1a provides the extra bioener-
getic support required under conditions of increased energy
demand.
Materials and Methods
Materials and reagents. All reagents used in this paper were
supplied from Sigma-Aldrich (St. Louis, Missouri, United States),
unless stated.
Animal care. Animals were housed in a temperature-controlled
room with a 12-h light/dark cycle. Food and water were available ad
libitum unless noted. All animal protocols used in this study were
approved by the UK Home Ofﬁce, The Institutional Animal Care and
Use Committee of the University of Utah, United States, and the
Animal Ethics Committees of Gothenburg and North Stockholm,
Sweden. Mice were cared for according to the Guiding Principles for
Research Involving Animals and Human Beings.
Generation of PGC1bKO mice. A triple LoxP strategy was used to
target the PGC-1b locus in order to generate mice with both
standard and conditional KO alleles at this locus. The targeting
vector was a ;8 kilobase (kb) 129/SvJ mouse genomic subclone
containing a ﬂoxed neomycin phosphotransferase selectable marker
cassette inserted into intron 3 and a single LoxP site inserted into
intron 5 (Figure 1A). The targeting construct was electroporated
into R1 ES cells, and neomycin-resistant clones were selected in G-
418-containing media. The clone was injected into C57Bl/6
blastocysts and chimeric males were crossed to C57Bl/6 females.
Heterozygous triple LoxP mice were then bred to ROSA26Cre [25]
mice in order to generate heterozygous PGC-1b KO mice which had
undergone Cre-mediated deletion of the intervening region of DNA
between the outermost LoxP sites. PCR analysis gave a product of
approximately 0.5 kb for the Cre-recombined allele and products of
approximately 2.8 and 0.6 kb with the WT allele (Figure 1D).
Heterozygous PGC-1b KO mice were then intercrossed to generate
mice that were homozygous for the PGC-1b deletion. Null mutants
were veriﬁed using RNA prepared from heart and skeletal muscle to
demonstrate that exons 4 and 5 had been deleted in the PGC1bKO
mice. Mice used for this research were backcrossed between three
and six times to a C57BL6/J background. Littermate controls were
used for all experiments. A more complete description for this
section can be found in the Protocol S1.
Long-term feeding and growth studies. Mice were placed at
weaning (3-wk-old) on normal chow diet (12% fat, 62% carbohy-
drates, and 26% protein with a total energy content of 12.6 kJ/g) (R3
diet, Lactamin AB, Stockholm, Sweden). Mouse weights were taken at
the same time each week, until the end of the speciﬁc protocol
period. Mice were routinely housed at 22 8C, except for those used for
the BAT activity and cold acclimatisation experiments (see below).
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Acute dietary measurements and interventions. To examine 48-h
food intake, cages (233 16 cm) were prepared with normal chow and
incubated at 80 8C for 1 h to correct for any differences in humidity.
After 2 h at room temperature, the cages were accurately weighed.
12-h-fasted mice were put in preweighed cages with free access to
food and water. After 48 h, the mice were removed and all faecal
matter was collected. The cages were reincubated at 80 8C in order to
dry out waterspill and urine, and then reweighed after 2 h cooling.
The difference in weights of the cage before and after the 48-h
assessment produced the weight of food consumed. For measurement
of energy content of faeces and food, samples were dried at 55 8C
overnight and stored in airtight containers at 20 8C until assayed.
The gross energy content of the dried samples was determined using
a bomb calorimeter (C5000, IKA Werke GmbH & Co., KG, Germany).
To assess the effect of 24-h high-fat feeding, 8-wk-old female mice
were assigned into two groups: ad libitum normal food or ad libitum
Surwit diet (58% of calories derived from fat, predominantly
hydrogenated coconut oil; D12331, Research Diets, New Brunswick,
New Jersey, United States). Start of the 24-h period was 9 am. At the
end of the time period, mice were killed and dissected as above.
Water was freely available during all procedures.
Body composition and indirect calorimetry. For body composition
analysis, dual energy x-ray absorptiometry (DEXA, GE Medical
Systems Lunar Corporation, Madison, Wisconsin, United States) was
performed on isoﬂurane anaesthetized mice as previously described
[26]. Oxygen consumption (VO2) and carbon dioxide production
(VCO2) were measured using the Oxymax system (Columbus Instru-
ments International, Columbus, Ohio, United States) [27]. Further
details can be found in Protocol S1.
GTTs and ITTs on mice fed chow and HFDs were performed as
previously described [26].
Cold acclimatisation and BAT activity. PGC1bKO mice and WT
littermates were exposed to 30 8C for 3 wk, placed at 18 8C for 1 wk,
and then exposed to 4 8C for 3 wk or kept at 30 8C for the duration of
the protocol. For both 30 8C and 4 8C acclimated animals, resting
metabolic rate was measured in awake animals at 30 8C. In addition,
NE-stimulated (1 mg NE/kg body weight in saline, () arterenol
bitartrate, intraperitoneally administered) energy expenditure was
evaluated in anaesthetized (pentobarbital, 90 mg/kg) animals at 33 8C.
Animals were allowed to recover from NE administration for 2–3 h at
30 8C. The mice where then rehoused at their acclimatisation
temperature for 1 wk prior to tissue collection for gene and protein
expression analysis to avoid effects of NE on gene expression. Oxygen
consumption in conscious animals was followed for 3 h using an open
circuit system with a chamber volume of 3 l and a ﬂow rate of 1 l/min
(Somedic, Ho¨rby, Sweden). This system allowed the ambient temper-
ature of the instruments to be adjusted between 5 8C and 40 8C,
together with the volume and ﬂow rates to optimise the system for
the particular investigation. Oxygen consumption, carbon dioxide
release, and ambient temperature data were collected every second
minute via MacLab/2e (AD Instruments Pty. Ltd., Castle Hill,
Australia). Resting metabolic rate was deﬁned as the average of the
lowest metabolic rates observed at three time points. Determinations
in WT and PGC1bKO mice were performed in alternating order.
Catherization and dobutamine treatment. Mice were anesthetized
with isoﬂurane and underwent endotracheal intubation. The airway
was connected to mouse ventilator (Model 687, Harvard Apparatus,
Holliston, Massachusetts, United States) to control breathing. The
oxygen ﬂow rate was 1 l/min. The left jugular vein was identiﬁed and
accessed by cut down method using a 25 G needle connected to a
syringe with dobutamine hydrochloride (Sigma) that was mounted on
a Standard Infuse/Withdraw Harvard 33 Twin Syringe Pump
(Harvard Apparatus). A micromanometer-tipped catheter (Millar
Instruments, Houston, Texas, United States) was then inserted into
the left ventricle via right carotid artery, and hemodynamic
measurements was obtained as described [28]. After obtaining
baseline left ventricular pressure and heart rate readings, the
dobutamine infusion was commenced. The initial infusion rate was
10 ng/min/g BW, with hemodynamic recordings taken at 2, 4, and 6
min. The infusion rate was then increased to 40 ng/min/g BW, and
additional readings were obtained at 2, 4, and 6 min after the dose
adjustment.
Tissue collection and RNA extractions. Mice were anaesthetised
using isoﬂourane. Blood, tissues used for RNA, protein extraction,
and histology were prepared as previously published [26,29].
Biochemical analysis. Enzymatic assay kits were used for determi-
nation of basic blood biochemical parameters as described in [26,29].
The size distribution proﬁles of serum lipoproteins were measured in
pooled plasma samples using a high-performance liquid chromatog-
raphy system (HPLC), SMART, and a Superose 6 PC 3.2/30 column as
described before [30].
Histological sample preparation and analysis. Tissue samples for
morphological analysis were prepared according to published
protocols [29]. For light microscopy, sections were stained with
haematoxylin and eosin. For adipose tissue, images of each section
were acquired using a digital camera and microscope (Olympus
BX41, Olympus Corporation, Tokyo, Japan) and adipocyte area was
measured using AnalySIS software (Soft Imaging System, Mu¨nster,
Germany). Two ﬁelds from each section from gonadal, subcuta-
neous, and omental adipose tissue depots (n ¼ 7–8 mice per
genotype) were analysed to obtain the mean cell area per animal.
For preparation of BAT, soleus muscle, and hearts for electron
microscopy, mice were exsanguinated by perfusion with physiolog-
ical saline containing 0.1% sodium nitrate until no blood was left.
Mice were then perfused with 60–90 ml of ﬁxative (3% glutaralde-
hyde and 1% formaldehyde in 0.1 mol/l 1,4-piperazine diethane
sulfonic acid (PIPES) buffer (pH 7.4) containing 2 mol/l calcium
chloride). Isotropic uniform random planes of section through the
left ventricular wall in hearts were prepared using the orientator
principle as described in [31]. Soleus samples were prepared at
equal lengths along the long axis of the muscle. The blocks of tissue
were sectioned in small fragments with a razor blade to ,1 mm in
one dimension and ﬁxed by immersion at 4 8C for a further 3–4 h.
Samples were then washed in 0.1 M PIPES and post-ﬁxed in 1%
osmium tetroxide, dehydrated in acetone, and embedded in Spurr’s
epoxy resin. Thin sections were obtained with a Leica UCT
ultramicrotome (Leica Microsystems, Milton Keynes, United King-
dom) and examined with a transmission electron microscope
(CM100, Philips, Netherlands).
Stereological assessment of mitochondria. Stereological assess-
ments of mitochondrial volume fractions (Vv) and the surface density
(SV) of their inner and outer membranes in heart were performed as
described in [31] and in [32].
Permeabilised tissue and isolated mitochondrial respiration
studies. Isolation of mitochondria was performed in hearts and
skeletal muscle from 10-wk-old male PGC-1b mice and their WT
littermates. Mice were killed by cervical dislocation. The hearts or
hind limb skeletal muscle of four mice per genotype were pooled
and immediately placed in ice-cold isolation medium (for hearts,
250 mM sucrose, 5 mM Tris, 2 mM EGTA at pH 7.4; for skeletal
muscle, 100 mM KCl, 50 mM Tris, 2 mM EGTA at pH 7.4).
Mitochondria were prepared essentially as described in [33].
Mitochondrial respiration was assessed in saponin-skinned soleus
ﬁbres prepared as in [14,34].
Measurement of proton conductance and ETC function in isolated
mitochondria. The kinetics of proton conductance and ETC function
were measured in mitochondria in the presence of oligomycin (1 lg/
ml), where that rate of respiration is directly proportional to the leak
of protons across the mitochondrial inner membrane rather than a
combination of ADP phosphorylation and proton leak. Mitochon-
drial function was assessed as described previously [35,36].
Quantitative RT-PCR analysis of gene expression. Total RNA was
isolated from tissues as described and reverse-transcribed using the
SuperscriptII kit (Invitrogen, Frederick, Maryland, United States) or
Hi-Capacity cDNA archive kit (Applied Biosystems, Foster City,
California, United States), following the manufacturers protocol.
Oligonucleotide primers and TaqMan probe were designed using
Primer Express, version 2.0 (Applied Biosytems). Primer and probe
sequences, together with gene abbreviations, can be found in Tables
S4–S6.
Microarray analysis.Male 14-wk-old mice were killed and dissected
as above. The tissues were extracted for RNA as above and puriﬁed
using the RNA clean-up protocol from the RNeasy Mini Kit (Qiagen
Ltd, Crawley, UK). RNA was quantiﬁed spectroscopically at 260 nm
using a GeneQuant Nucleotide calculator (Amersham Biosciences,
Little Chalfont, UK) and checked for integrity on a 1% TBE gel using
ethidium bromide staining. cDNA was ampliﬁed from total RNA
using template-switching PCR and labeled with Cy3 or Cy5 dyes as
previously described [37]. Binomial pathway enrichment analysis was
then performed. A more detailed protocol can be found in Protocol
S1. Raw data from the analysis are presented in Dataset S1 (pathway
comparison) and Dataset S2 (raw data from the chip analysis).
Mitochondrial isolation, protein extraction, and Western analysis.
Female 15-wk-old chow-fed mice were anaesthetised using isoﬂurane
and killed by cervical dislocation and heart removal. BAT, heart,
and soleus muscle tissue was removed and either snap-frozen in
liquid nitrogen or used to prepare a mitochondrial extract as
described in Protocol S1. In general, 10 lg of total lysate or 3 lg of
mitochondrial preparation was separated by SDS-PAGE on 14%
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gels. After transfer, the membranes were cut and placed in blocking
buffer (5% powdered milk in 13 PBS and 0.1% Tween-20). We used
anti-OxPhos complex I (a-subcomplex 9) and anti-OxPhos complex
III (Fe-S core protein) (Molecular Probes, Carlsbad, California,
United State) and anti-succinate dehydrogenase subunit B, anti-
Cox4, and anti-ATP synthase b-subunit from Abcam, Cambridge,
UK. All primary antibodies were used at ratios of 1:2,000, except
anti-Cox4, which was used at 1:20,000. Goat anti-mouse horseradish
peroxidase secondary antibody (Pierce, Rockford, Illinois, United
States) was used at 1:40,000 for all blots, the membranes were
reassembled, and the proteins detected using the ECL-Plus system
(Amersham Biosystems). Films were scanned and analysed using NIH
Image 1.34s.
Statistical analysis. The data presented here were analysed using
the Student t-test or analysis of variance (ANOVA) with post-hoc tests
on the program StatView Version 4.5 (Abacus Concepts, Berkley,
California, United States). Data are presented as mean 6 SEM unless
stated. p , 0.05 was considered signiﬁcant. The signiﬁcance levels
displayed on ﬁgures are as follows: * indicates p, 0.05, ** indicates p
, 0.01, *** indicates p , 0.001.
Supporting Information
Dataset S1. Data Used for the Comparative Pathway Analysis of BAT,
Heart, and Liver Tissues Using KEGG and KEGG2 Pathways
Found at DOI: 10.1371/journal.pbio.0040369.sd001 (62 KB XLS).
Dataset S2. Raw Data Text Files from the Spotted Array Experiments
on Heart, Liver, and BAT Used in the Comparative Pathway Analysis
Found at DOI: 10.1371/journal.pbio.0040369.sd002 (3.2 MB XLS).
Figure S1. Size Distribution of Adipocytes from WT and PGC1bKO
Mice
Two ﬁelds from each section from (A) omental WAT, (B) subcuta-
neous WAT, and (C) female gonadal WAT depots (age 24 wk, n¼ 7–8
mice per genotype) were analysed to obtain the mean cell area per
animal.
Found at DOI: 10.1371/journal.pbio.0040369.sg001 (43 KB PPT).
Figure S2. Histological Sections of Tissues
Sections are as follows: BAT (A and B), liver (C and D), soleus muscle
(E and F), pancreatic sections stained for glucagon (G and H), or
pancreatic sections stained for insulin (I and J). A representative
section fromWT (A, C, E, G, and I) or PGC1bKO (B, D, F, H, and J) are
shown, n¼6.
Found at DOI: 10.1371/journal.pbio.0040369.sg002 (1.7 MB PDF).
Figure S3. Deletion of PGC-1b Does Not Affect Insulin Sensitivity
Mice were placed on normal diet or HFD for 13 wk. GTTs (left panels)
or ITTs (right panels) were performed on the mice at 16 wk of age.
Plasma glucose levels of WT mice (open circles) and PGC1bKO (solid
circles) were measured during the protocol.
Found at DOI: 10.1371/journal.pbio.0040369.sg003 (115 KB PPT).
Figure S4. Expression of mRNAs Assessed on Soleus from 12-wk-Old
Male WT (Black Bars) and PGC1bKO (White Bars) Mice
Individual measurements were standardised using 18S, and the
average of the WT group set to 1. n ¼ 6 mice per group.
Found at DOI: 10.1371/journal.pbio.0040369.sg004 (34 KB PPT).
Figure S5. Assessment of Isolated Soleus Mitochondrial Function
from WT and PGC1bKO Mice
SoleustissuewaspooledfromfourWTmice(blackbars)orfourPGC1bKO
mice(whitebars)andmitochondriaisolatedonﬁveseparateoccasions(n
¼5). Respiration states (A) were calculated using oxygen consumption
rates in isolated mitochondria energised with succinate (4 mM).
Respiratorycontrolratios(B)weredeterminedformitochondriaasstate
3dividedby state 4. Proton leak kinetics (C)weremeasuredas described
underMaterials andMethods.
Found at DOI: 10.1371/journal.pbio.0040369.sg005 (35 KB PPT).
Figure S6. PGC-1b Ablation Results in Few Changes in Gene
Expression in Liver
Gene expression was analysed in 12-wk-old fed-state male WT (black
bars) and PGC1bKO (white bars) livers. Individual measurements are
standardised using 18S and then the average of the WT group was set
to 1. n ¼ 6 mice per group.
Found at DOI: 10.1371/journal.pbio.0040369.sg006 (36 KB PPT).
Figure S7. Gene Expression of PGC-1a and PGC-1b (A) and for a
Selection of Genes Involved with Fatty Acid and Cholesterol
Handling in the Liver (B) in 8-wk-Old Female Mice Fed Surwit Diet
for 24 h
WT chow, black bars; WT Surwit HFD, white bars; PGC1bKO chow,
dark gray bars; PGC1bKO Surwit HFD, light gray bars. Individual
measurements are standardised using 36B4 and then the average of
the WT chow group was set to 1. n ¼ 4–7 per condition.
Found at DOI: 10.1371/journal.pbio.0040369.sg007 (35 KB PPT).
Protocol S1. Supplementary Protocols
Found at DOI: 10.1371/journal.pbio.0040369.sd003 (99 KB DOC).
Table S1. WT and PGC1bKO Mouse Parameters for Energy Intake
and Faecal Output over 48 h
The food intake and energetic content of faeces from 12-wk-old male
mice was determined over a 48-h period. n ¼ 5–8 per group.
Found at DOI: 10.1371/journal.pbio.0040369.st001 (21 KB DOC).
Table S2. WT and PGC1bKO Tissue Weights in 14-wk-Old Male Mice
The data are presented both comparing raw weights and as tissue
weight/body weight. Statistical comparison between WT and
PGC1bKO mice was performed using t-tests. n ¼ 6–8 per group. p
values are shown where p is less than or equal to 0.2.
Found at DOI: 10.1371/journal.pbio.0040369.st002 (25 KB DOC).
Table S3. Comparison of KEGG Pathways Signiﬁcantly Down-
regulated in all Three Arrayed Tissues (Liver, BAT, and Heart)
RNA was isolated from 14-wk-old normal diet-fed male PGC1bKO
and WT mice and then analysed using spotted arrays as described in
the Materials and Methods. Data from these chips were then analysed
using for pathway changes using the KEGG pathway database.
Pathways with only one changed gene were discounted. Data are
displayed as pathway name followed by p value for the binomial test.
A pathway p value of ,0.05 was considered signiﬁcant.
Found at DOI: 10.1371/journal.pbio.0040369.st003 (22 KB DOC).
Table S4. Sequences for Taqman Primers and Probes
Sybr as a probe indicates the use of a Sybr-Green system instead of
Taqman.
Found at DOI: 10.1371/journal.pbio.0040369.st004 (31 KB DOC).
Table S5. Sequences for Taqman Primers and Probes
Sybr as a probe indicates the use of a Sybr-Green system instead of
Taqman.
Found at DOI: 10.1371/journal.pbio.0040369.st005 (29 KB DOC).
Table S6. Sequences for Taqman Primers and Probes
Sybr as a probe indicates the use of a Sybr-Green system instead of
Taqman.
Found at DOI: 10.1371/journal.pbio.0040369.st006 (29 KB DOC).
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